EOM Pharmaceuticals Holdings, Inc. (IMUC)
0.11
0.00 (0.00%)
USD |
OTCM |
Feb 23, 09:30
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.4613M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -29.94% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.69% |
Profile
| EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded by Eli Goldberger and Shalom Z. Hirschman on March 20, 1987 and is headquartered in Montvale, NJ. |
| URL | http://www.eompharma.com |
| Investor Relations URL | http://investors.imuc.com/index.cfm |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 14, 2018 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded by Eli Goldberger and Shalom Z. Hirschman on March 20, 1987 and is headquartered in Montvale, NJ. |
| URL | http://www.eompharma.com |
| Investor Relations URL | http://investors.imuc.com/index.cfm |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 14, 2018 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |